{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:01:42Z","timestamp":1780920102341,"version":"3.54.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jogc.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T17:17:55Z","timestamp":1700068675000},"page":"102143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guideline No. 443a: Opioid Use Throughout Women\u2019s Lifespan: Fertility, Contraception, Chronic Pain, and Menopause"],"prefix":"10.1016","volume":"45","author":[{"given":"Suzanne","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelynn L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2023.05.011_bib1","series-title":"Canadian Community Health Survey","year":"2019"},{"key":"10.1016\/j.jogc.2023.05.011_bib2","first-page":"224","article-title":"The opioid crisis in Canada: a national perspective. Health promotion and chronic disease prevention in Canada","volume":"38","author":"Belzak","year":"2018"},{"key":"10.1016\/j.jogc.2023.05.011_bib3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","article-title":"Effective Canadian policy to reduce harms from prescription opioids: learning from past failures","volume":"188","author":"Fischer","year":"2016","journal-title":"Canadian Medical Association journal (CMAJ)"},{"key":"10.1016\/j.jogc.2023.05.011_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jogc.2023.05.011_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00952990.2011.596982","article-title":"Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial","volume":"37","author":"Back","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jogc.2023.05.011_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210341","article-title":"Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study","volume":"14","author":"Oh","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2023.05.011_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence","volume":"45","author":"McHugh","year":"2013","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jogc.2023.05.011_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/10903127.2015.1076096","article-title":"Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts","volume":"20","author":"Sumner","year":"2016","journal-title":"Prehosp Emerg Care"},{"key":"10.1016\/j.jogc.2023.05.011_bib13","article-title":"Guideline No. 440b: Opioid use throughout the Women\u2019s Lifespan: Opioid Use in Pregnancy and Breastfeeding","volume":"44","author":"Turner","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.011_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.vh.2019.07.001","article-title":"Opioids and reproduction","volume":"111","author":"Seeber","year":"2019","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jogc.2023.05.011_bib15","article-title":"Opioids and pituitary function","author":"Gadelha","year":"2022","journal-title":"expert opinion. Pituitary"},{"key":"10.1016\/j.jogc.2023.05.011_bib16","first-page":"105","article-title":"Opioids and the Hypothalamic-Pituitary-Gonadal (HPG) Axis","author":"Wehbeh","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.05.011_bib17","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.05.011_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mayocp.2016.09.018","article-title":"Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review","volume":"92","author":"Goldstein","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jogc.2023.05.011_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejp.1256","article-title":"Increased risk of reproductive dysfunction in women prescribed long-term opioids for musculoskeletal pain: A matched cohort study in the Clinical Practice Research Datalink","volume":"22","author":"Richardson","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jogc.2023.05.011_bib20","first-page":"28","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jogc.2023.05.011_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.reprotox.2016.09.006","article-title":"Dramatic acceleration of reproductive aging, contraction of biochemical fecundity and healthspan-lifespan implications of opioid-induced endocrinopathy-FSH\/LH ratio and other interrelationships","volume":"66","author":"Reece","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jogc.2023.05.011_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jogc.2023.05.011_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","article-title":"The impact of opioids on the endocrine system","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jogc.2023.05.011_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/EDE.0000000000001247","article-title":"Is opioid use safe in women trying to conceive?","volume":"31","author":"Flannagan","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.jogc.2023.05.011_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40834-018-0056-y","article-title":"Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences","volume":"3","author":"Fischbein","year":"2018","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jogc.2023.05.011_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.whi.2018.10.004","article-title":"Perceptions of Pregnancy and Contraceptive Use: An In-Depth Study of Women in Los Angeles Methadone Clinics","volume":"29","author":"Bornstein","year":"2019","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.jogc.2023.05.011_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/JCE2022332112","article-title":"Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder","volume":"33","author":"Abbass","year":"2022","journal-title":"J\u00a0Clin Ethics"},{"key":"10.1016\/j.jogc.2023.05.011_bib29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/add.13840","article-title":"Prescription contraception use and adherence by women with substance use disorders","volume":"112","author":"Griffith","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.011_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00981389.2020.1769249","article-title":"Contraceptive use in Appalachian women who use drugs and were recruited from rural jails","volume":"59","author":"Ely","year":"2020","journal-title":"Soc Work Health Care"},{"key":"10.1016\/j.jogc.2023.05.011_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.contraception.2017.07.167","article-title":"Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder","volume":"96","author":"Matusiewicz","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2023.05.011_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2022.02.013","article-title":"Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy","volume":"110","author":"Melbostad","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2023.05.011_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2019.08.006","article-title":"Safety and effectiveness of hormonal contraception for women who use opioids: A systematic review","volume":"100","author":"Ti","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2023.05.011_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10826084.2017.1327976","article-title":"Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances","volume":"53","author":"Loree","year":"2018","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.jogc.2023.05.011_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ypmed.2016.06.023","article-title":"Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy","volume":"92","author":"Heil","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/1753-6405.13025","article-title":"Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study","volume":"44","author":"Day","year":"2020","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.jogc.2023.05.011_bib37","article-title":"Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review","volume":"32","author":"Charron","year":"2023","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.jogc.2023.05.011_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.srhc.2022.100764","article-title":"Factors associated with contraceptive use among postpartum women with substance use disorder","volume":"33","author":"Shelton","year":"2022","journal-title":"Sex Reprod Healthc"},{"key":"10.1016\/j.jogc.2023.05.011_bib39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/1475-6773.14075","article-title":"Trusted contraception information sources for individuals with opioid use disorder","volume":"57","author":"Sobel","year":"2022","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jogc.2023.05.011_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233185","article-title":"Exploring stress, cognitive, and affective mechanisms of the relationship between interpersonal trauma and opioid misuse","volume":"15","author":"Williams","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2023.05.011_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.amepre.2020.06.019","article-title":"Sexual Violence, Mental Health, and Prescription Opioid Use and Misuse","volume":"59","author":"Austin","year":"2020","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib42","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10597-020-00661-0","article-title":"Prevalence of Adverse Childhood Experiences of Parenting Women in Drug Treatment for Opioid Use Disorder","volume":"57","author":"Gannon","year":"2021","journal-title":"Community Ment Health J"},{"key":"10.1016\/j.jogc.2023.05.011_bib43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fpsyt.2019.00674","article-title":"Profiles of Childhood Trauma in Women With Substance Use Disorders and Comorbid Posttraumatic Stress Disorders","volume":"10","author":"Lotzin","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.011_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/pm\/pnz233","article-title":"The Impact of Childhood Emotional Abuse on Pain Interference Among People with Chronic Pain who Inject Drugs in Vancouver, Canada","volume":"21","author":"Prangnell","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.AOG.0000258296.35538.88","article-title":"Trauma and posttraumatic stress disorder in women with chronic pelvic pain","volume":"109","author":"Meltzer-Brody","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1037\/tra0000511","article-title":"Association between posttraumatic stress disorder and nonfatal drug overdose","volume":"12","author":"Lee","year":"2020","journal-title":"Psychol Trauma"},{"key":"10.1016\/j.jogc.2023.05.011_bib47","article-title":"Conceptualizing and Treating Comorbid Chronic Pain and PTSD","volume":"2013","author":"Bosco","year":"2013","journal-title":"Pain Res Treat"},{"key":"10.1016\/j.jogc.2023.05.011_bib48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/1524838018821950","article-title":"The Role of Trauma and Mental Health in the Treatment of Chronic Pelvic Pain: A Systematic Review of the Intervention Literature","volume":"21","author":"Panisch","year":"2020","journal-title":"Trauma Violence Abuse"},{"key":"10.1016\/j.jogc.2023.05.011_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/GRF.0000000000000411","article-title":"Selecting the Appropriate Patient for Opioid Therapy: Risk Assessment and Treatment Strategies for Gynecologic Pain","volume":"62","author":"Findley","year":"2019","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib50","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1093\/milmed\/usy114","article-title":"A\u00a010-yr Analysis of Chronic Pelvic Pain and Chronic Opioid Therapy in the Women Veteran Population","volume":"183","author":"Cichowski","year":"2018","journal-title":"Mil Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib51","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jmig.2022.09.013","article-title":"Opioid Use After Laparoscopic Surgery for Endometriosis and Pelvic Pain","volume":"29","author":"Heres","year":"2022","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000003267","article-title":"Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With Benzodiazepines","volume":"133","author":"Lamvu","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jmig.2020.05.029","article-title":"Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study","volume":"28","author":"As-Sanie","year":"2021","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/jwh.2021.0060","article-title":"Surgical and Pharmacological Treatment Patterns in Women with Endometriosis: A Descriptive Analysis of Insurance Claims","volume":"31","author":"Weaver","year":"2022","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2023.05.011_bib55","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2022.00028","article-title":"Intraoperative Factors Associated with More Postoperative Opioid Use after Laparoscopic Hysterectomy","volume":"26","author":"Zhang","year":"2022","journal-title":"JSLS"},{"key":"10.1016\/j.jogc.2023.05.011_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.urology.2017.11.009","article-title":"Impact of Cystectomy With Urinary Diversion Upon Tracked Receipt of Opioid Prescriptions Among Patients With Interstitial Cystitis\/Bladder Pain Syndrome","volume":"114","author":"Koslov","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jogc.2023.05.011_bib57","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SPV.0000000000001195","article-title":"Relationship Between Opioid Prescriptions and Number of Chronic Pain Conditions in Women With Interstitial Cystitis","volume":"28","author":"Duncan","year":"2022","journal-title":"Urogynecology (Phila)"},{"key":"10.1016\/j.jogc.2023.05.011_bib58","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2023.05.011_bib59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jmig.2019.04.017","article-title":"Postoperative Opioid Use Using Enhanced Recovery After Surgery Guidelines for Benign Gynecologic Procedures","volume":"27","author":"Movilla","year":"2020","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ijgc-2018-000131","article-title":"Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service","volume":"29","author":"Schwartz","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2023.05.011_bib61","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2022.00041","article-title":"Risk Factors for Postoperative Narcotic Use in Benign, Minimally-Invasive Gynecologic Surgery","volume":"26","author":"Frost","year":"2022","journal-title":"JSLS"},{"key":"10.1016\/j.jogc.2023.05.011_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-6576.2007.01552.x","article-title":"Chronic pain after hysterectomy","volume":"52","author":"Brandsborg","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jogc.2023.05.011_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12871-016-0270-6","article-title":"Prevalence and risk factors for chronic pain following cesarean section: a prospective study","volume":"16","author":"Jin","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jogc.2023.05.011_bib64","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2023.05.011_bib65","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2023.05.011_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.23736\/S0375-9393.20.14822-3","article-title":"Chronic cancer and non-cancer pain and opioid-induced hyperalgesia share common mechanisms: neuroinflammation and central sensitization","volume":"87","author":"Santoni","year":"2021","journal-title":"Minerva Anestesiol"},{"issue":"Suppl 2","key":"10.1016\/j.jogc.2023.05.011_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/add.13675","article-title":"Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA's SBIRT initiative for substance abuse policy and practice","volume":"112","author":"Babor","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.011_bib68","first-page":"305","article-title":"Motivational interviewing: a systematic review and meta-analysis","volume":"55","author":"Rubak","year":"2005","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jogc.2023.05.011_bib69","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1360-0443.2012.03870.x","article-title":"Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study","volume":"107","author":"Nosyk","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.011_bib70","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2023.05.011_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.011_bib72","series-title":"A\u00a0Review of Comparative Clinical Effectiveness, Cost-Effectiveness and Guidelines","year":"2016"},{"key":"10.1016\/j.jogc.2023.05.011_bib73","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.jogc.2023.05.011_bib75","author":"Taha"},{"key":"10.1016\/j.jogc.2023.05.011_bib76","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.drugalcdep.2018.10.015","article-title":"An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain","volume":"194","author":"Barry","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.011_bib77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13011-022-00466-2","article-title":"Becoming our young people's case managers: caregivers' experiences, needs, and ideas for improving opioid use treatments for young people using opioids","volume":"17","author":"Marchand","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jogc.2023.05.011_bib78","article-title":"Opioid Use Disorder: Treatments and Barriers","volume":"13","author":"Patel","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jogc.2023.05.011_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13011-020-00314-1","article-title":"A\u00a0scoping review of school-based indigenous substance use prevention in preteens (7-13 years)","volume":"15","author":"Maina","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jogc.2023.05.011_bib81","first-page":"3974","article-title":"Prescription opioid prescribing, use\/misuse, harms and treatment among Aboriginal people in Canada: a narrative review of available data and indicators","volume":"16","author":"Russell","year":"2016","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.jogc.2023.05.011_bib82","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1465-3362.2010.00258.x","article-title":"The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities","volume":"30","author":"Yang","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jogc.2023.05.011_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108165","article-title":"Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada","volume":"121","author":"Wendt","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jogc.2023.05.011_bib84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.17269\/s41997-018-0055-4","article-title":"Community strengths in addressing opioid use in Northeastern Ontario","volume":"109","author":"Dorman","year":"2018","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jogc.2023.05.011_bib85","first-page":"137","article-title":"Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study","volume":"63","author":"Mamakwa","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jogc.2023.05.011_bib86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.15288\/jsad.2014.75.259","article-title":"Prescription drug misuse and sexual risk behaviors among adolescents and emerging adults","volume":"75","author":"Bonar","year":"2014","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.jogc.2023.05.011_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e3181d916db","article-title":"HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study","volume":"55","author":"Meade","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2023.05.011_bib88","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s10461-012-0335-6","article-title":"Sexual risk behavior associated with transition to injection among young non-injecting heroin users","volume":"17","author":"Mackesy-Amiti","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jogc.2023.05.011_bib89","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/02791072.2013.785811","article-title":"Prescription drug misuse and risk behaviors among young injection drug users","volume":"45","author":"Johnson","year":"2013","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.jogc.2023.05.011_bib90","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.amepre.2019.05.017","article-title":"Prescription Opioid Misuse Associated With Risk Behaviors Among Adolescents","volume":"57","author":"Clayton","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib91","article-title":"Medication-Assisted Treatment of Adolescents With Opioid Use Disorders","volume":"138","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogc.2023.05.011_bib92","series-title":"A\u00a0Guideline for the Clinical Management of Opioid Use Disorder","year":"2017"},{"key":"10.1016\/j.jogc.2023.05.011_bib93","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1015","article-title":"Prevalence and Risk Factors of Nonmedical Prescription Opioid Use Among Transgender Girls and Young Women","volume":"3","author":"Restar","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2023.05.011_bib94","first-page":"13","article-title":"Significant factors associated with problematic use of opioid pain relief medications among the household population, Canada, 2018","volume":"32","author":"Carri\u00e8re","year":"2021","journal-title":"Health Rep"},{"key":"10.1016\/j.jogc.2023.05.011_bib95","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jgs.14512","article-title":"Frequency and Predictors of Analgesic Prescribing in U.S. Nursing Home Residents with Persistent Pain","volume":"65","author":"Fain","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jogc.2023.05.011_bib96","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1532-5415.2004.52251.x","article-title":"Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents","volume":"52","author":"Won","year":"2004","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jogc.2023.05.011_bib97","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jgs.14306","article-title":"New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents","volume":"64","author":"Pimentel","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jogc.2023.05.011_bib98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpain.2004.07.011","article-title":"Opioid use in the elderly","volume":"9","author":"Wilder-Smith","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jogc.2023.05.011_bib99","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(08)60656-X","article-title":"Assessment of pain: a community-based diary survey in the USA","volume":"371","author":"Krueger","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2023.05.011_bib100","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1111\/jgs.18030","article-title":"Prescription opioids and longitudinal changes in cognitive function in older adults: A population-based observational study","volume":"70","author":"Warner","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jogc.2023.05.011_bib101","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jwh.2015.5222","article-title":"Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain","volume":"24","author":"LeResche","year":"2015","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2023.05.011_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jogc.2023.05.011_bib103","doi-asserted-by":"crossref","first-page":"e0128232","DOI":"10.1371\/journal.pone.0128232","article-title":"Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies","volume":"10","author":"Teng","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.jogc.2023.05.011_bib104","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/pds.4362","article-title":"Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights","volume":"27","author":"Yoshida","year":"2018","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"10.1016\/j.jogc.2023.05.011_bib105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/TCRM.S79409","article-title":"The unsolved case of \"bone-impairing analgesics\": the endocrine effects of opioids on bone metabolism","volume":"11","author":"Coluzzi","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jogc.2023.05.011_bib106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","article-title":"Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)","volume":"23","author":"Vestergaard","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jogc.2023.05.011_bib107","volume":"13","author":"Shadid","year":"2013"},{"key":"10.1016\/j.jogc.2023.05.011_bib108","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/aje\/kwt013","article-title":"Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database","volume":"178","author":"Li","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jogc.2023.05.011_bib109","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7150\/ijms.52201","article-title":"Factors Associated with Low Bone Density in Opioid Substitution Therapy Patients: A Systematic Review","volume":"18","author":"Ramli","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jogc.2023.05.011_bib110","first-page":"1257-e418","article-title":"Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population","volume":"57","author":"Kahan","year":"2011","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"10.1016\/j.jogc.2023.05.011_bib112","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s11606-019-05242-w","article-title":"Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain","volume":"34","author":"Gibson","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib114","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2023.05.011_bib115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.AOG.0000441353.20693.78","article-title":"141: management of menopausal symptoms","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.05.011_bib117","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jogc.2021.09.001","article-title":"Guideline No. 422b: Menopause and Genitourinary Health","volume":"43","author":"Johnston","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.05.011_bib118","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jogc.2023.05.011_bib119","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.011_bib120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11904-010-0059-z","article-title":"Drug treatment as HIV prevention: expanding treatment options","volume":"7","author":"Metzger","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jogc.2023.05.011_bib121","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jogc.2023.05.011_bib122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","article-title":"A\u00a0randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification","volume":"94","author":"Gruber","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jogc.2023.05.011_bib123","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jogc.2023.05.011_bib124","article-title":"Product Monograph Iincluding Patient Medication Information: NBuTrans\u00ae 5, NBuTrans\u00ae 10, NBuTrans\u00ae 15, NBuTrans\u00ae 20, Buprenorphine Transdermal System, Patch, 5, 10, 15 and 20 mcg\/h, Transdermal, Purdue Pharma Standard","year":"2021","journal-title":"Opioid Analgesic"},{"key":"10.1016\/j.jogc.2023.05.011_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/03639045.2013.846365","article-title":"Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine\/naloxone tablet formulation in healthy volunteers","volume":"41","author":"Fischer","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jogc.2023.05.011_bib126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/dar.12344","article-title":"Diversion and injection of buprenorphine\u2013naloxone film two years post-introduction in Australia","volume":"35","author":"Larance","year":"2016","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jogc.2023.05.011_bib127","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jogc.2023.05.011_bib128","unstructured":"Canadian Research Initiative in Substance Misuse. CRISM National Guideline for the Clinical Management of Opioid Use Disorder."},{"key":"10.1016\/j.jogc.2023.05.011_bib130","series-title":"Buprenorphine Formulations in Pregnancy: Safety & Efficacy Considerations for Canadians","year":"2021"},{"key":"10.1016\/j.jogc.2023.05.011_bib131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-020-00392-1","article-title":"Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran","volume":"17","author":"Nakhaeizadeh","year":"2020","journal-title":"Harm reduction journal"},{"key":"10.1016\/j.jogc.2023.05.011_bib132","article-title":"Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting","author":"Berk","year":"2021","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.jogc.2023.05.011_bib133","first-page":"Cd009879","article-title":"Slow-release oral morphine as maintenance therapy for opioid dependence","author":"Ferri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2023.05.011_bib134","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.011_bib135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction","volume":"207","author":"Strang","year":"2015","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jogc.2023.05.011_bib136","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13011-021-00360-3","article-title":"\"They're not doing enough.\": women's experiences with opioids and naloxone in Toronto","volume":"16","author":"Macleod","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.jogc.2023.05.011_bib137","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2146\/ajhp170759","article-title":"Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center","volume":"75","author":"Zschoche","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jogc.2023.05.011_bib138","first-page":"538","article-title":"Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians","volume":"61","author":"Leece","year":"2015","journal-title":"Can Fam Physician"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:43:45Z","timestamp":1761666225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216323003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":129,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1701216323003808"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2023.05.011","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 443a: Opioid Use Throughout Women\u2019s Lifespan: Fertility, Contraception, Chronic Pain, and Menopause","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102143"}}